VICKIE L. CAPPS - 29 Feb 2024 Form 4 Insider Report for Janux Therapeutics, Inc. (JANX)

Role
Director
Signature
/s/ Maria Dobek, Attorney-in-Fact
Issuer symbol
JANX
Transactions as of
29 Feb 2024
Net transactions value
$0
Form type
4
Filing time
04 Mar 2024, 16:33:17 UTC
Previous filing
05 Sep 2023
Next filing
07 May 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction JANX Common Stock Other $0 +1,493 +2.3% $0.000000 65,543 29 Feb 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents receipt of securities in a pro rata, in-kind distribution of securities, by ABV SPV I GP LLC, of which Reporting Person is a member.